{"filings":[{"id":108841,"accession_number":"0001628280-26-022434","cik":1808220,"company_name":"GoHealth, Inc.","ticker":"GOCO","form_type":"8-K","filed_at":"2026-03-31T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"GoHealth reports FY2025 results with no financial figures; emphasizes intentional MA pullback and cash discipline","summary_kind":"llm","event_type":"earnings","confidence":"low","bullets":["No GAAP or adjusted EPS, revenue, or net income provided in the press release.","Company intentionally pulled back Medicare Advantage activity in 2025 citing market structural reset.","Focus on retention, high-quality member book, and durability of commission receivable asset.","Continued leadership in Special Needs Plans (SNP) and targeted investment in AI/automation.","Management highlights strategic flexibility, cash optimization, and consolidation readiness."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":19632592.88919192,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":108840,"accession_number":"0001628280-26-020176","cik":1808220,"company_name":"GoHealth, Inc.","ticker":"GOCO","form_type":"8-K","filed_at":"2026-03-20T23:59:59+00:00","items":["3.01","9.01"],"status":"ready","headline":"GoHealth receives Nasdaq delisting notice for failure to meet $35M market value requirement","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Notice dated March 18, 2026 for non-compliance with MVLS Requirement (min $35M market value of listed securities).","Also fails alternative standards: stockholders' equity ≥$2.5M or net income from continuing ops of $500K.","180-day compliance period until September 14, 2026 to regain compliance.","No immediate effect on listing; common stock continues trading on Nasdaq under GOCO.","Company evaluating options to regain compliance, but no assurance of success."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":19632592.88919192,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":125295,"accession_number":"0001628280-25-051840","cik":1808220,"company_name":"GoHealth, Inc.","ticker":"GOCO","form_type":"8-K","filed_at":"2025-11-13T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"GoHealth reports Q3 2025 results with intentional MA volume pullback; no financial figures disclosed","summary_kind":"llm","event_type":"earnings","confidence":"low","bullets":["Intentionally reduced Medicare Advantage volume in response to health plan focus on renewal stability and unit economics.","Secured superpriority term loan facility and received covenant relief to strengthen strategic flexibility.","Refreshed Board of Directors to enable potential integration and consolidation opportunities.","Preserved core capabilities: agent enablement technology, retention operations, and back-book value.","Leadership maintained in Special Needs Plans where health plans continue allocating resources."],"consensus_eps_estimate":null,"consensus_eps_actual":-19.14,"consensus_revenue_estimate":null,"consensus_revenue_actual":349206000.0,"consensus_period":"2025-Q3","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":19632592.88919192,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":142017,"accession_number":"0001808220-25-000069","cik":1808220,"company_name":"GoHealth, Inc.","ticker":"GOCO","form_type":"8-K","filed_at":"2025-08-19T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"GoHealth appoints Mark Weinsten and Bao Truong to board; Gelber and Modi resign","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Jeremy W. Gelber and Abhiraj Modi resigned from the Board effective August 19, 2025; no disagreement with company.","Mark Weinsten appointed Class II director; receives $25,000 monthly cash retainer plus expense reimbursement.","Bao Truong appointed Class III director; serves on Transformation, Compensation, and Nominating & Governance Committees; no compensation as Centerbridge employee.","Both appointments effective immediately; Weinsten term expires 2028, Truong 2026; both standard indemnification agreements.","Both nominated as Centerbridge designees under Stockholders Agreement."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":19632592.88919192,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":142016,"accession_number":"0001628280-25-038578","cik":1808220,"company_name":"GoHealth, Inc.","ticker":"GOCO","form_type":"8-K","filed_at":"2025-08-07T23:59:59+00:00","items":["1.01","2.02","2.03","3.02","5.02","9.01"],"status":"ready","headline":"GoHealth secures $115M superpriority term loan, amends credit agreement, and appoints three new directors","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Secured $115M superpriority term loan facility with $80M in new-money term loans and $35M in roll-up loans.","Amended existing credit agreement to waive principal payments through 2026 and reset financial covenants.","Issued 4,766,219 shares of Class A common stock to lenders as consideration for the amendment.","Appointed Timothy R. Pohl, Alan J. Carr, and William L. Transier to the board; three directors resigned.","Reported Q2 2025 financial results and announced transformation committee for strategic alternatives."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.9,"calibrated_materiality_score":0.9,"market_cap_usd":19632592.88919192,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":159981,"accession_number":"0001628280-25-033527","cik":1808220,"company_name":"GoHealth, Inc.","ticker":"GOCO","form_type":"8-K","filed_at":"2025-06-30T23:59:59+00:00","items":["1.01","2.03","7.01","9.01"],"status":"ready","headline":"GoHealth extends revolver maturity to Sep 30, waives financial covenants for Q2/Q3, allows receivables financing","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Extends revolving credit maturity from June 30 to September 30, 2025, and waives financial covenant testing for Q2 and Q3 2025.","Interest on certain loans may be paid in-kind through September 30, 2025, increasing principal balance.","Consents to pursue receivables financing or securitization as part of comprehensive refinancing plan.","Weekly cash flow forecasts and variance reports required; milestones: business plan by July 15, financing docs by Aug 7.","Amendment fee of 1.00% of commitments and outstanding term loans, payable in-kind."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":19632592.88919192,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":159980,"accession_number":"0001628280-25-032314","cik":1808220,"company_name":"GoHealth, Inc.","ticker":"GOCO","form_type":"8-K","filed_at":"2025-06-20T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"GoHealth stockholders elect three Class II directors and approve all proposals at 2025 annual meeting","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Elected Brandon M. Cruz, Alan Wheatley, and Abhiraj R. Modi as Class II directors with >95% of votes cast.","Ratified Ernst & Young as independent auditor for FY2025: 21.5M for, 557K against, 47K abstained.","Advisory approval of executive compensation passed: 17.0M for, 992K against, 27K abstained.","Approved amendment to 2020 Incentive Award Plan: 16.8M for, 1.3M against, 2.4K abstained."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":19632592.88919192,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":159979,"accession_number":"0001808220-25-000044","cik":1808220,"company_name":"GoHealth, Inc.","ticker":"GOCO","form_type":"8-K","filed_at":"2025-05-13T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"GoHealth Q1 net revenue $221M (+19% YoY); Adjusted EBITDA $42.1M (+56%)","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net revenue $221.0M, up 19.1% YoY from $185.6M; net loss narrowed to $9.8M from $21.3M.","Adjusted EBITDA $42.1M, up 56.4% from $26.9M; Submissions 303,026, up 40.2% YoY.","Direct Operating Cost per Submission $522, an 18.4% improvement from $640 YoY.","Launched GoHealth Protect with guaranteed acceptance life insurance to diversify offerings.","CEO cited platform improvements and expanded product suite; no guidance change provided."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.52,"consensus_revenue_estimate":null,"consensus_revenue_actual":220972000.0,"consensus_period":"2025-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":19632592.88919192,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":159978,"accession_number":"0001808220-25-000037","cik":1808220,"company_name":"GoHealth, Inc.","ticker":"GOCO","form_type":"8-K","filed_at":"2025-04-07T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"GoHealth extends CEO Kotte's contract to 2028; $1M salary, $5M equity, $3M cash retention","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["CEO term extended to April 1, 2028; base salary raised to $1M per year.","2025 annual equity grant of $5M in RSUs vesting over 3 years (185k shares now, remainder pending shareholder approval).","Separate retention award: 500k immediate-vest RSUs and $3M cash ($1.5M now, $1.5M by Jan 2026 tied to performance).","Severance benefits now include death; Change in Control definition expanded to include going-private transactions.","Retention award subject to pro-rata clawback if CEO voluntarily leaves before three-year anniversary."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":19632592.88919192,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":178310,"accession_number":"0001808220-25-000005","cik":1808220,"company_name":"GoHealth, Inc.","ticker":"GOCO","form_type":"8-K","filed_at":"2025-02-27T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"GoHealth Q4 net revenue up 41% to $389M; net income $58M vs prior year loss","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 net revenues $389.1M (+41% YoY); full-year net revenues $798.9M (+9% YoY).","Q4 net income $58.0M vs $(2.3)M prior year; full-year net loss improved to $(7.3)M from $(151.3)M.","Q4 adjusted EBITDA $117.8M (+107% YoY); full-year adjusted EBITDA $120.3M (+60% YoY).","Submissions grew 67% in Q4 to 481,445; full-year submissions 1,016,182 (+23% YoY).","Refinanced credit facility; e-TeleQuote integration drove growth and efficiency gains."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.66,"consensus_revenue_estimate":null,"consensus_revenue_actual":798894000.0,"consensus_period":"2024-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":19632592.88919192,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":194969,"accession_number":"0001808220-24-000125","cik":1808220,"company_name":"GoHealth, Inc.","ticker":"GOCO","form_type":"8-K","filed_at":"2024-11-07T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"GoHealth Q3 net income $15.4M vs loss $56.2M; acquires e-TeleQuote at bargain gain $77.4M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q3 net revenues $118.3M, down $13.7M from $132.0M a year ago.","Net income of $15.4M compared to a net loss of $56.2M in Q3 2023.","Adjusted EBITDA negative $12.1M, slightly worse than negative $11.5M prior year.","Completed acquisition of e-TeleQuote, adding $90.5M contract assets and $22.5M cash; recorded $77.4M gain on bargain purchase.","Direct Operating Cost per Submission improved 11.0% YoY; appointed Brendan Shanahan as CFO."],"consensus_eps_estimate":null,"consensus_eps_actual":-3.14,"consensus_revenue_estimate":null,"consensus_revenue_actual":409762000.0,"consensus_period":"2024-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":19632592.88919192,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":194968,"accession_number":"0001808220-24-000118","cik":1808220,"company_name":"GoHealth, Inc.","ticker":"GOCO","form_type":"8-K","filed_at":"2024-10-10T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"GoHealth appoints Brendan Shanahan as CFO; O'Halloran becomes CAO","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Brendan Shanahan appointed CFO effective Oct 14, 2024; has 30+ years financial leadership and Medicare Advantage expertise.","Katherine O'Halloran, interim CFO, transitions to Chief Accounting Officer and will report to Shanahan.","Shanahan receives $500k base salary, 80% target bonus, 150k RSUs vesting over 3 years, and $50k signing bonus.","No financial results or guidance changes; planned executive succession with no unexpected departures."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":19632592.88919192,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":194967,"accession_number":"0001808220-24-000115","cik":1808220,"company_name":"GoHealth, Inc.","ticker":"GOCO","form_type":"8-K","filed_at":"2024-10-01T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"GoHealth closes acquisition of e-TeleQuote; gains ~$100M in contract assets and $18M cash","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Acquisition closed on Sept 30, 2024; GoHealth invested $5M for newly issued shares and became sole owner after previous owner relinquished 81.1% stake.","e-TeleQuote contributes over $100M in contract assets (Medicare Advantage) and $18M cash to GoHealth's balance sheet.","e-TeleQuote brings nearly 400 licensed agents; will operate under GoPartner Solutions with access to GoHealth's PlanFit tools and marketing channels.","CEO Vijay Kotte cites potential for reduced marketing capacity industry-wide and strong Medicare Advantage demand as favorable backdrop.","Interim CFO expects positive impact on Revenue, Adjusted EBITDA, and Cash Flow from Operations in Q4 and beyond."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":19632592.88919192,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":211259,"accession_number":"0001808220-24-000108","cik":1808220,"company_name":"GoHealth, Inc.","ticker":"GOCO","form_type":"8-K","filed_at":"2024-09-04T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"GoHealth to acquire e-TeleQuote Insurance, gaining full ownership by Sept 30, 2024","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["GoHealth subsidiary will acquire newly issued shares representing ~18.9% of e-TeleQuote, then current parent surrenders all rights, making ETQ wholly-owned.","Transaction expected to close on or before September 30, 2024, subject to customary conditions.","Deal combines GoHealth's proprietary technology and scale with e-TeleQuote's talent and track record to enhance Medicare marketplace.","No purchase price disclosed; both companies emphasize consumer-first approach and seamless integration.","GoHealth CEO Vijay Kotte and e-TeleQuote CEO Craig Uchytil expressed confidence in the mutually accretive relationship."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":19632592.88919192,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":211258,"accession_number":"0001808220-24-000099","cik":1808220,"company_name":"GoHealth, Inc.","ticker":"GOCO","form_type":"8-K","filed_at":"2024-08-08T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"GoHealth Q2 2024 net revenues $105.9M, down 26% YoY; net loss improves to $59.3M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net revenues of $105.9M, a decrease of $36.9M from $142.8M in Q2 2023.","Submissions of 152,394, down 6% YoY; internal captive agents grew, offset by GoPartner Solutions decline.","Net loss of $59.3M, an improvement of $10.9M from prior year loss of $70.2M.","Adjusted EBITDA of negative $12.3M vs positive $0.8M YoY, a decrease of $13.1M.","TTM cash flow from operations of $53.8M, down from $85.9M in prior period."],"consensus_eps_estimate":null,"consensus_eps_actual":-3.76,"consensus_revenue_estimate":null,"consensus_revenue_actual":291470000.0,"consensus_period":"2024-Q2","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":19632592.88919192,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":211257,"accession_number":"0001808220-24-000080","cik":1808220,"company_name":"GoHealth, Inc.","ticker":"GOCO","form_type":"8-K","filed_at":"2024-07-10T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"GoHealth appoints two new directors, Alan Wheatley and Abhiraj Modi; Christopher Litchford resigns","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Alan Wheatley, former President of Medicare at Humana (1991-2022), appointed as Class II director effective July 9, 2024.","Abhiraj R. Modi, Managing Director at Centerbridge Partners, appointed as Class II director as Centerbridge designee, effective July 9, 2024.","Christopher C. Litchford resigned effective July 8, 2024; resignation not related to any disagreement with the Company.","Wheatley receives annual retainer of $150,000 and RSU award of $150,000 (pro-rated); Modi receives no additional compensation.","Wheatley appointed to Nominating and Corporate Governance Committee; Modi not appointed to any committee initially."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"market_cap_usd":19632592.88919192,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":229813,"accession_number":"0001808220-24-000074","cik":1808220,"company_name":"GoHealth, Inc.","ticker":"GOCO","form_type":"8-K","filed_at":"2024-06-25T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Director Joseph G. Flanagan resigns from GoHealth Board; Alexander Timm named lead independent director","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Joseph G. Flanagan resigned from Board effective June 25, 2024; served as Class II director and Chair of Nominating and Corporate Governance Committee.","Resignation not related to any disagreement with Company on operations, policies, or practices.","Alexander Timm replaces Flanagan as lead independent director."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":19632592.88919192,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":229809,"accession_number":"0001808220-24-000071","cik":1808220,"company_name":"GoHealth, Inc.","ticker":"GOCO","form_type":"8-K/A","filed_at":"2024-06-21T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"GoHealth awards interim CFO Katherine O'Halloran $75k bonus and 25k RSUs","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Former CFO Jason Schulz resigned effective June 4, 2024; Katherine O'Halloran appointed interim CFO.","O'Halloran receives $75,000 retention bonus payable upon appointment of a permanent CFO.","O'Halloran awarded 25,000 Restricted Stock Units vesting in equal annual installments over three years."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":19632592.88919192,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":229812,"accession_number":"0001808220-24-000061","cik":1808220,"company_name":"GoHealth, Inc.","ticker":"GOCO","form_type":"8-K","filed_at":"2024-06-14T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"GoHealth stockholders elect three directors, ratify auditor, approve say-on-pay at 2024 annual meeting","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Alexander Timm (17.6M for), David Fisher (17.3M for), Vijay Kotte (17.8M for) elected Class I directors.","Ernst & Young ratified as independent auditor for FY2024: 21.3M for, 30.8K against, 17.2K abstain.","Advisory vote on named executive officer compensation approved: 17.6M for, 359K against, 3.1K abstain.","All three proposals passed; annual meeting held June 12, 2024."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"market_cap_usd":19632592.88919192,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":229811,"accession_number":"0001808220-24-000057","cik":1808220,"company_name":"GoHealth, Inc.","ticker":"GOCO","form_type":"8-K","filed_at":"2024-06-04T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"GoHealth CFO Jason Schulz resigns; CAO Katherine O'Halloran named interim CFO","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Jason Schulz resigned as CFO effective June 4, 2024, for personal reasons; no disagreement with company.","Katherine O'Halloran, current Chief Accounting Officer, appointed interim CFO while permanent search conducted.","Schulz will serve as non-executive consultant through September 1, 2024 to assist transition.","O'Halloran has over 30 years experience; previously CFO at VanEnkevort Tug & Barge and VP at Great Lakes Dredge & Dock.","O'Halloran's interim CFO compensation not yet finalized; current base salary $325k with 50% target bonus."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":19632592.88919192,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":229810,"accession_number":"0001808220-24-000049","cik":1808220,"company_name":"GoHealth, Inc.","ticker":"GOCO","form_type":"8-K","filed_at":"2024-05-09T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"GoHealth Q1 net revenues $185.6M, up slightly; net loss narrows to $21.3M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net revenues of $185.6M vs $183.2M in Q1 2023, a slight increase.","Net loss of $21.3M, improving from $22.5M in prior year period.","Adjusted EBITDA of $26.9M, down from $28.8M YoY.","Submissions of 216,148, up 2,503 from 213,645 YoY.","TTM cash flow from operations of $101.2M vs $26.9M in prior year period."],"consensus_eps_estimate":null,"consensus_eps_actual":-1.04,"consensus_revenue_estimate":null,"consensus_revenue_actual":185600000.0,"consensus_period":"2024-Q1","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":19632592.88919192,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}